Yes—addressing high blood pressure can likely reduce cognitive decline and may lower dementia risk. The evidence is stronger for preventing mild cognitive impairment than for preventing dementia itself. Addressing high blood pressure means diagnosing hypertension and following a clinician-guided plan. The World Health Organization identifies blood pressure management as one way to reduce cognitive-decline and dementia risk across the life course in its 2025 dementia fact sheet.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What does the research show?
- Why is dementia prevention still uncertain?
- Who may not be represented by the trial?
- What blood pressure target should you discuss?
- What can you do now?
What does the research show?
The strongest trial evidence comes from SPRINT MIND. It included 9,361 adults aged 50 or older who had hypertension and elevated cardiovascular risk. Participants were assigned a systolic blood pressure target below either 120 or 140 mm Hg.
Systolic pressure is the top number in a blood pressure reading. Intensive treatment reduced mild cognitive impairment from 18.3 to 14.6 cases per 1,000 person-years, according to the 2019 JAMA trial report. A person-year represents one person followed for one year.
Why is dementia prevention still uncertain?
SPRINT MIND did not find a statistically significant reduction in probable dementia alone. Rates were 7.2 versus 8.6 cases per 1,000 person-years. The result could not rule out chance, so it did not prove that intensive treatment prevents dementia. Seven-year follow-up still found fewer combined cases of mild cognitive impairment or probable dementia: 20.1 versus 22.9 per 1,000 person-years.
However, probable dementia alone remained nonsignificant in the 2025 Neurology follow-up. A 2020 JAMA meta-analysis of randomized trials found a similarly modest benefit. Dementia or cognitive impairment occurred in 7.0% of participants receiving blood pressure treatment and 7.5% of comparison participants over 4.1 years. That was an absolute difference of 0.39 percentage points.
Who may not be represented by the trial?
SPRINT stopped its blood pressure intervention early because of cardiovascular benefit. That shortened the time available to detect dementia, which generally requires longer observation than cardiovascular events. The trial also excluded people with diabetes, prior stroke, advanced kidney disease, or symptomatic heart failure.
Its results therefore do not directly establish the right target for people with those conditions. These limits do not mean blood pressure treatment lacks cognitive value. They mean readers should view cognitive protection as likely rather than guaranteed, especially when applying the findings beyond the trial population.
What blood pressure target should you discuss?
The 2025 American Heart Association and American College of Cardiology guideline recommends a systolic goal below 130 mm Hg for adults with hypertension to help prevent mild cognitive impairment and dementia, as stated in the published hypertension guideline. That recommendation differs from automatically pursuing SPRINT's intensive target below 120 mm Hg. A clinician should choose an appropriate goal based on the individual rather than using a research target as a universal rule.
What can you do now?
The practical priority is to diagnose and manage hypertension with a clinician. Blood pressure treatment has established cardiovascular benefits, with likely cognitive benefit as an added reason to address it.
Useful questions for an appointment include: These studies evaluated the prevention of cognitive outcomes; they did not establish blood pressure lowering as a treatment that reverses existing dementia. Treat an intensive target as part of individualized medical care, not as a proven stand-alone dementia-prevention therapy.
- Do my readings indicate hypertension?
- What systolic target is appropriate for me?
- Do my medical conditions make the SPRINT findings less applicable?
- How will we assess whether my treatment plan is working?
